Industry
Alligator Bioscience Slashes 70% of Workforce Due to Financial Strains
Alligator Bioscience, staff cuts, capital constraints, biopharma industry, financial challenges
Alligator Bioscience Cuts 70% of Workforce to Address Financial Challenges and Refocus on Pancreatic Cancer Research
Alligator Bioscience, layoffs, cost-cutting, pancreatic cancer research, financial constraints, biotech industry
Kronos Undergoes Major Restructuring: CEO Norbert Bischofberger Exits Amid 83% Workforce Reduction
Kronos layoffs, Norbert Bischofberger, biotech industry, workforce reduction, restructuring
Alector Cuts 17% of Workforce Following Failure of AbbVie-Partnered Alzheimer’s Drug in Phase 2 Trial
Alector, layoffs, AbbVie, Alzheimer’s disease, phase 2 trial failure, biotech industry
Navigating JPM Week 2024: Insights and Opportunities in Biopharma
JPM Week 2024, Biopharma, Industry Insights, Networking, Deal-making, Investment, M&A, IPOs, Regulatory Trends
Halozyme Therapeutics Abandons $2.1 Billion Acquisition Bid for Evotec Due to Lack of Engagement
Halozyme Therapeutics, Evotec, acquisition bid, withdrawal, lack of engagement, biotech industry
CSL Behring to Close California R&D Site Amid Shift in Gene Therapy Strategy
CSL Behring, California R&D site closure, ex vivo gene therapy, strategic repositioning, biotech industry trends
RFK Jr.’s HHS Nomination: A Potential Threat to the Biopharma Industry
RFK Jr., HHS nomination, biopharma industry, vaccine skepticism, health policies, Trump administration
Gilead Sciences and Kite Pharma Announce Layoffs, Closure of Seattle and Philadelphia Offices
Gilead Sciences, Kite Pharma, layoffs, office closures, Seattle, Philadelphia, biotech industry, restructuring
Charles River Laboratories Embarks on Restructuring, Closing 15 Smaller Sites Amid Declining Demand for Early Research Services
Charles River Laboratories, restructuring, site closures, declining demand, early research services, cost-cutting measures, biotech industry challenges.